Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results for: December 03, 2008

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Alvesco New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Keppra XR New Drug Initial Review Require Prior Approval Prior Approval Required
Venlafaxine ER New Drug Initial Review Require Prior Approval Prior Approval Required
Pataday New Drug Initial Review Remove Prior Approval Requirement Prior Approval Requirement Removed
Factive New Drug Appeal Require Prior Approval Prior Approval Required
Patanase New Drug Appeal Remove Prior Approval Requirement Prior Approval Requirement Removed
Altabax New Drug Appeal Require Prior Approval Prior Approval Required
Ranexa New Drug Appeal Require Prior Approval Prior Approval Required
Suprax Suspension PDL Appeal Require Prior Approval Prior Approval Required